Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 775, pseudogene (abbreviated RN7SL775P) is a non-functional segment of DNA similar in sequence to the functional 7SL RNA gene, but it has lost the ability to produce functional RNA and does not encode a protein. 7SL RNA is a structural component of the signal recognition particle (SRP) involved in cotranslational targeting of secretory proteins, but the pseudogene copy, RN7SL775P, does not participate in this pathway or have known biological functions. Pseudogenes such as RN7SL775P are considered "genomic fossils" and are not targets for drug action, biomarkers, or implicated in disease mechanisms, although in rare cases some pseudogenes may have regulatory roles; there is no evidence for RN7SL775P being such a case[4][7]. Reasoning and Key Points: - RN7SL775P is a pseudogene for the 7SL RNA, not the functional SRP RNA. It is not a functional molecule and does not encode a functional product[4][7]. - It is not a therapeutic target, as it is not a receptor, enzyme, transporter, or similar molecule class. There is no evidence that it is involved in disease or therapeutic pathways[4][7]. - Pseudogenes are widespread in the genome and can complicate molecular genetic studies, but this does not make them targets or disease-relevant molecules by themselves[4]. - There is no evidence for disease association, drug interaction, mechanism of action, biomarker status, or unique molecular function for RN7SL775P in the current biomedical literature. If you need information on the functional 7SL RNA or the signal recognition particle, please clarify, as the above entry concerns only this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 775, pseudogene (RN7SL775P).